Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Apr;28(4):617-618.
doi: 10.1016/j.cmi.2021.12.025. Epub 2022 Jan 10.

ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply

Michele Bartoletti  1 , Ozlem Azap  2 , Aleksandra Barac  3 , Linda Bussini  4 , Onder Ergonul  5 , Robert Krause  6 , Alejandro Martín-Quirós  7 , José Ramon Paño-Pardo  8 , Nicholas Power  9 , Marcella Sibani  10 , Balint Szabo  11 , Sotirios Tsiodras  12 , Ines Zollner-Schwetz  6 , Jesús Rodriguez-Baño  13 ; ESCMID COVID-19 Treatment Guidelines Panel
Affiliations
Comment

ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply

Michele Bartoletti et al. Clin Microbiol Infect. 2022 Apr.
No abstract available

PubMed Disclaimer

Comment on

  • ESCMID COVID-19 living guidelines: drug treatment and clinical management.
    Bartoletti M, Azap O, Barac A, Bussini L, Ergonul O, Krause R, Paño-Pardo JR, Power NR, Sibani M, Szabo BG, Tsiodras S, Verweij PE, Zollner-Schwetz I, Rodríguez-Baño J. Bartoletti M, et al. Clin Microbiol Infect. 2022 Feb;28(2):222-238. doi: 10.1016/j.cmi.2021.11.007. Epub 2021 Nov 22. Clin Microbiol Infect. 2022. PMID: 34823008 Free PMC article.

References

    1. Dauby N. Re: 'ESCMID COVID-19 living guidelines: drug treatment and clinical management' by Bartoletti et al. Clin Microbiol Infect. 2022;28:616. - PMC - PubMed
    1. Beigel J.H., Tomashek K.M., Dodd L.E., Mehta A.K., Zingman B.S., Kalil A.C., et al. Remdesivir for the treatment of COVID-19–Final report. N Engl J Med. 2020;383:1813–1826. - PMC - PubMed
    1. Pan H., Peto R., Henao-Restrepo A.M., Preziosi M.P., Sathiyamoorthy V., Abdool Karim Q., et al. WHO Solidarity Trial Consortium Repurposed antiviral drugs for COVID-19–Interim WHO solidarity trial results. N Engl J Med. 2021;384:497–511. - PMC - PubMed
    1. Bartoletti M., Azap O., Barac A., Bussini L., Ergonul O., Krause R., et al. ESCMID COVID-19 living guidelines: drug treatment and clinical management. Clin Microbiol Infect. 2021;S1198–743X 0. - PMC - PubMed
    1. Goncalves A., Bertrand J., Ke R.A., Comets E., de Lamballerie X., Malvy D., et al. Timing of antiviral treatment initiation is critical to reduce SARS-CoV-2 viral load. CPT Pharmacometrics Syst Pharmacol. 2020;9:509–514. - PMC - PubMed